Entered into a settlement agreement with J.H. Darbie & Co. to resolve outstanding obligations under previous advisory and placement agreements. Settlement terms include the issuance of 400 shares of Series D Preferred Stock and a $175,000 cash payment plan. Cash payments are structured as seven equal monthly installments of $25,000, ending December 31, 2026. Majority shareholder (Rennova Health, Inc.) approved a reverse stock split at a ratio between 1:1,000 and 1:1,0000. The previously approved 2025 reverse stock split plan has been formally abandoned.